UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 525

Sortiert nach

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Journal of Crohn's & colitis, 2010-02, Vol.4 (1), p.28-62

2010

Volltextzugriff (PDF)

Systematic review with network meta‐analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2017-05, Vol.45 (10), p.1303-1318

2017

Volltextzugriff (PDF)

An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease

Alimentary pharmacology & therapeutics, 2018-08, Vol.48 (3), p.347-357

2018

Volltextzugriff (PDF)

Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation

Alimentary pharmacology & therapeutics, 2014-11, Vol.40 (9), p.991-1008

2014

Volltextzugriff (PDF)

Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study

Alimentary pharmacology & therapeutics, 2016-12, Vol.44 (11-12), p.1199-1212

2016

Volltextzugriff (PDF)

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease

Journal of Crohn's and colitis, 2014-10, Vol.8 (10), p.1179-1207

2014

Volltextzugriff (PDF)

Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2003-05, Vol.17 (10), p.1273-1281

2003

Volltextzugriff (PDF)

Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2020-03, Vol.14 (3), p.316-322

2020

Volltextzugriff (PDF)

IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management

Digestive diseases and sciences, 2024-03, Vol.69 (3), p.749-765

2024

Volltextzugriff (PDF)

Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells

Gut, 2005-02, Vol.54 (2), p.228-236

2005

Volltextzugriff (PDF)

Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation?

Gut, 2006-03, Vol.55 (3), p.342-347

2006

Volltextzugriff (PDF)

Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies—authors' reply

Alimentary pharmacology & therapeutics, 2017-10, Vol.46 (7), p.705-706

2017

Volltextzugriff (PDF)

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study

Gut, 2005-07, Vol.54 (7), p.960-965

2005

Volltextzugriff (PDF)

Clinical relevance of transabdominal ultrasonography and magnetic resonance imaging in patients with inflammatory bowel disease of the terminal ileum and large bowel

Inflammatory bowel diseases, 2004-07, Vol.10 (4), p.373-382

2004

Volltextzugriff (PDF)

Clinical trial: five or ten cycles of granulocyte–monocyte apheresis show equivalent efficacy and safety in ulcerative colitis

Alimentary pharmacology & therapeutics, 2010-06, Vol.31 (12), p.1286-1295

2010

Volltextzugriff (PDF)

P-208Pre-therapy physical function and body status of patients with advanced gastrointestinal cancer compared to breast cancer patients and healthy women

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii60-ii60

2016

Volltextzugriff (PDF)

Editorial: which iron preparation for patients with IBD? Authors’ reply

Alimentary pharmacology & therapeutics, 2017-07, Vol.46 (2), p.195-196

2017

Volltextzugriff (PDF)

Letter: inconsistency in reporting of hypophosphataemia after intravenous iron—authors’ reply

Alimentary pharmacology & therapeutics, 2017-09, Vol.46 (6), p.643-644

2017

Volltextzugriff (PDF)

Letter: a case supporting the use of rescue infliximab therapy for fulminant ulcerative colitis in pregnancy – authors’ reply

Alimentary pharmacology & therapeutics, 2015-02, Vol.41 (3), p.326-326

2015

Volltextzugriff (PDF)

Letter: leucocytapheresis as a nonpharmacologic treatment for patients with ulcerative colitis during pregnancy – authors’ reply

Alimentary pharmacology & therapeutics, 2015-01, Vol.41 (2), p.235-236

2015

Volltextzugriff (PDF)

Editorial: the management of IBD during pregnancy and lactation – author's reply

Alimentary pharmacology & therapeutics, 2014-11, Vol.40 (10), p.1248-1248

2014

Volltextzugriff (PDF)

Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids

Carcinogenesis (New York), 2007-09, Vol.28 (9), p.1991-1995

2007

Volltextzugriff (PDF)

Mechanisms and modulation of intestinal epithelial repair

Inflammatory bowel diseases, 2001-02, Vol.7 (1), p.68-77

Dignass, Axel U.

2001

Volltextzugriff (PDF)

Letter: inflammatory bowel disease guidelines and conflicts of interest

Alimentary pharmacology & therapeutics, 2013-08, Vol.38 (4), p.445-445

2013

Volltextzugriff (PDF)

Cytokine modulation of intestinal epithelial cell restitution: Central role of transforming growth factor β

Gastroenterology (New York, N.Y. 1943), 1993-11, Vol.105 (5), p.1323-1332

1993

Volltextzugriff (PDF)

1 – 25 von 525

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(496)
Mit Volltextzugriff
(445)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Systematic review with network meta‐analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease

An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease

Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation

Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease

Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease

Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease

IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management

Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells

Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation?

Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies—authors' reply

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study

Clinical relevance of transabdominal ultrasonography and magnetic resonance imaging in patients with inflammatory bowel disease of the terminal ileum and large bowel

Clinical trial: five or ten cycles of granulocyte–monocyte apheresis show equivalent efficacy and safety in ulcerative colitis

P-208Pre-therapy physical function and body status of patients with advanced gastrointestinal cancer compared to breast cancer patients and healthy women

Editorial: which iron preparation for patients with IBD? Authors’ reply

Letter: inconsistency in reporting of hypophosphataemia after intravenous iron—authors’ reply

Letter: a case supporting the use of rescue infliximab therapy for fulminant ulcerative colitis in pregnancy – authors’ reply

Letter: leucocytapheresis as a nonpharmacologic treatment for patients with ulcerative colitis during pregnancy – authors’ reply

Editorial: the management of IBD during pregnancy and lactation – author's reply

Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids

Mechanisms and modulation of intestinal epithelial repair

Letter: inflammatory bowel disease guidelines and conflicts of interest

Cytokine modulation of intestinal epithelial cell restitution: Central role of transforming growth factor β

Suchergebnisse filtern